Global Lurasidone Hydrochloride Generics Market Outlook, In‑Depth Analysis & Forecast to 2031

1 Study Coverage
1.1 Introduction to Lurasidone Hydrochloride Generics: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Lurasidone Hydrochloride Generics Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 20mg per Tablet
1.2.3 40mg per Tablet
1.2.4 60mg per Tablet
1.2.5 80mg per Tablet
1.2.6 120mg per Tablet
1.3 Market Segmentation by Application
1.3.1 Global Lurasidone Hydrochloride Generics Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Schizophrenia
1.3.3 Bipolar Depression
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Lurasidone Hydrochloride Generics Revenue Estimates and Forecasts 2020-2031
2.2 Global Lurasidone Hydrochloride Generics Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Lurasidone Hydrochloride Generics Sales Estimates and Forecasts 2020-2031
2.4 Global Lurasidone Hydrochloride Generics Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Lurasidone Hydrochloride Generics Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Lurasidone Hydrochloride Generics Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 20mg per Tablet Market Size by Manufacturers
3.5.2 40mg per Tablet Market Size by Manufacturers
3.5.3 60mg per Tablet Market Size by Manufacturers
3.5.4 80mg per Tablet Market Size by Manufacturers
3.5.5 120mg per Tablet Market Size by Manufacturers
3.6 Global Lurasidone Hydrochloride Generics Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Lurasidone Hydrochloride Generics Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Lurasidone Hydrochloride Generics Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Lurasidone Hydrochloride Generics Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Lurasidone Hydrochloride Generics Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Lurasidone Hydrochloride Generics Sales and Revenue by Type (2020-2031)
6.4 North America Lurasidone Hydrochloride Generics Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Lurasidone Hydrochloride Generics Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Lurasidone Hydrochloride Generics Sales and Revenue by Type (2020-2031)
7.4 Europe Lurasidone Hydrochloride Generics Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Lurasidone Hydrochloride Generics Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Lurasidone Hydrochloride Generics Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Lurasidone Hydrochloride Generics Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Lurasidone Hydrochloride Generics Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Lurasidone Hydrochloride Generics Sales and Revenue by Type (2020-2031)
9.4 Central and South America Lurasidone Hydrochloride Generics Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Lurasidone Hydrochloride Generics Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Lurasidone Hydrochloride Generics Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Lurasidone Hydrochloride Generics Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Lurasidone Hydrochloride Generics Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Accord Healthcare
11.1.1 Accord Healthcare Corporation Information
11.1.2 Accord Healthcare Business Overview
11.1.3 Accord Healthcare Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.1.4 Accord Healthcare Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Accord Healthcare Lurasidone Hydrochloride Generics Sales by Product in 2024
11.1.6 Accord Healthcare Lurasidone Hydrochloride Generics Sales by Application in 2024
11.1.7 Accord Healthcare Lurasidone Hydrochloride Generics Sales by Geographic Area in 2024
11.1.8 Accord Healthcare Lurasidone Hydrochloride Generics SWOT Analysis
11.1.9 Accord Healthcare Recent Developments
11.2 Amneal
11.2.1 Amneal Corporation Information
11.2.2 Amneal Business Overview
11.2.3 Amneal Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.2.4 Amneal Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Amneal Lurasidone Hydrochloride Generics Sales by Product in 2024
11.2.6 Amneal Lurasidone Hydrochloride Generics Sales by Application in 2024
11.2.7 Amneal Lurasidone Hydrochloride Generics Sales by Geographic Area in 2024
11.2.8 Amneal Lurasidone Hydrochloride Generics SWOT Analysis
11.2.9 Amneal Recent Developments
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Corporation Information
11.3.2 Dr. Reddy's Laboratories Business Overview
11.3.3 Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.3.4 Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Sales by Product in 2024
11.3.6 Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Sales by Application in 2024
11.3.7 Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Sales by Geographic Area in 2024
11.3.8 Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics SWOT Analysis
11.3.9 Dr. Reddy's Laboratories Recent Developments
11.4 MSN
11.4.1 MSN Corporation Information
11.4.2 MSN Business Overview
11.4.3 MSN Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.4.4 MSN Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 MSN Lurasidone Hydrochloride Generics Sales by Product in 2024
11.4.6 MSN Lurasidone Hydrochloride Generics Sales by Application in 2024
11.4.7 MSN Lurasidone Hydrochloride Generics Sales by Geographic Area in 2024
11.4.8 MSN Lurasidone Hydrochloride Generics SWOT Analysis
11.4.9 MSN Recent Developments
11.5 Sun Pharmaceuticals
11.5.1 Sun Pharmaceuticals Corporation Information
11.5.2 Sun Pharmaceuticals Business Overview
11.5.3 Sun Pharmaceuticals Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.5.4 Sun Pharmaceuticals Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Sun Pharmaceuticals Lurasidone Hydrochloride Generics Sales by Product in 2024
11.5.6 Sun Pharmaceuticals Lurasidone Hydrochloride Generics Sales by Application in 2024
11.5.7 Sun Pharmaceuticals Lurasidone Hydrochloride Generics Sales by Geographic Area in 2024
11.5.8 Sun Pharmaceuticals Lurasidone Hydrochloride Generics SWOT Analysis
11.5.9 Sun Pharmaceuticals Recent Developments
11.6 Alkem
11.6.1 Alkem Corporation Information
11.6.2 Alkem Business Overview
11.6.3 Alkem Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.6.4 Alkem Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Alkem Recent Developments
11.7 Zydus
11.7.1 Zydus Corporation Information
11.7.2 Zydus Business Overview
11.7.3 Zydus Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.7.4 Zydus Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Zydus Recent Developments
11.8 Lupin
11.8.1 Lupin Corporation Information
11.8.2 Lupin Business Overview
11.8.3 Lupin Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.8.4 Lupin Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Lupin Recent Developments
11.9 Alembic pharmaceuticals
11.9.1 Alembic pharmaceuticals Corporation Information
11.9.2 Alembic pharmaceuticals Business Overview
11.9.3 Alembic pharmaceuticals Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.9.4 Alembic pharmaceuticals Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Alembic pharmaceuticals Recent Developments
11.10 Yangtze River Pharmaceutical
11.10.1 Yangtze River Pharmaceutical Corporation Information
11.10.2 Yangtze River Pharmaceutical Business Overview
11.10.3 Yangtze River Pharmaceutical Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.10.4 Yangtze River Pharmaceutical Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Yangtze River Pharmaceutical Recent Developments
11.11 Qilu Pharmaceutical
11.11.1 Qilu Pharmaceutical Corporation Information
11.11.2 Qilu Pharmaceutical Business Overview
11.11.3 Qilu Pharmaceutical Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.11.4 Qilu Pharmaceutical Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Qilu Pharmaceutical Recent Developments
11.12 SJZ No.4 Pharmaceutical
11.12.1 SJZ No.4 Pharmaceutical Corporation Information
11.12.2 SJZ No.4 Pharmaceutical Business Overview
11.12.3 SJZ No.4 Pharmaceutical Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.12.4 SJZ No.4 Pharmaceutical Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 SJZ No.4 Pharmaceutical Recent Developments
11.13 Zhejiang Huahai Pharmaceutical
11.13.1 Zhejiang Huahai Pharmaceutical Corporation Information
11.13.2 Zhejiang Huahai Pharmaceutical Business Overview
11.13.3 Zhejiang Huahai Pharmaceutical Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.13.4 Zhejiang Huahai Pharmaceutical Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Zhejiang Huahai Pharmaceutical Recent Developments
11.14 Hansoh Pharma
11.14.1 Hansoh Pharma Corporation Information
11.14.2 Hansoh Pharma Business Overview
11.14.3 Hansoh Pharma Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.14.4 Hansoh Pharma Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Hansoh Pharma Recent Developments
11.15 YaoPharma
11.15.1 YaoPharma Corporation Information
11.15.2 YaoPharma Business Overview
11.15.3 YaoPharma Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.15.4 YaoPharma Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 YaoPharma Recent Developments
11.16 Changzhou Pharmaceutical Factory
11.16.1 Changzhou Pharmaceutical Factory Corporation Information
11.16.2 Changzhou Pharmaceutical Factory Business Overview
11.16.3 Changzhou Pharmaceutical Factory Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.16.4 Changzhou Pharmaceutical Factory Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Changzhou Pharmaceutical Factory Recent Developments
11.17 Shandong Jewim Pharmaceutical
11.17.1 Shandong Jewim Pharmaceutical Corporation Information
11.17.2 Shandong Jewim Pharmaceutical Business Overview
11.17.3 Shandong Jewim Pharmaceutical Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.17.4 Shandong Jewim Pharmaceutical Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Shandong Jewim Pharmaceutical Recent Developments
11.18 Hisun Pharmaceuticals
11.18.1 Hisun Pharmaceuticals Corporation Information
11.18.2 Hisun Pharmaceuticals Business Overview
11.18.3 Hisun Pharmaceuticals Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.18.4 Hisun Pharmaceuticals Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Hisun Pharmaceuticals Recent Developments
11.19 Cisen Pharmaceutical
11.19.1 Cisen Pharmaceutical Corporation Information
11.19.2 Cisen Pharmaceutical Business Overview
11.19.3 Cisen Pharmaceutical Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.19.4 Cisen Pharmaceutical Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Cisen Pharmaceutical Recent Developments
11.20 Chia Tai Tianqing Pharmaceutical
11.20.1 Chia Tai Tianqing Pharmaceutical Corporation Information
11.20.2 Chia Tai Tianqing Pharmaceutical Business Overview
11.20.3 Chia Tai Tianqing Pharmaceutical Lurasidone Hydrochloride Generics Product Models, Descriptions and Specifications
11.20.4 Chia Tai Tianqing Pharmaceutical Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Chia Tai Tianqing Pharmaceutical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Lurasidone Hydrochloride Generics Industry Chain
12.2 Lurasidone Hydrochloride Generics Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Lurasidone Hydrochloride Generics Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Lurasidone Hydrochloride Generics Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Lurasidone Hydrochloride Generics Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Lurasidone Hydrochloride Generics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

List of Tables
Table 1. Global Lurasidone Hydrochloride Generics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Lurasidone Hydrochloride Generics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Lurasidone Hydrochloride Generics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Lurasidone Hydrochloride Generics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Lurasidone Hydrochloride Generics Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Lurasidone Hydrochloride Generics Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Lurasidone Hydrochloride Generics Sales by Region (2020-2025) & (K Units)
Table 8. Global Lurasidone Hydrochloride Generics Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Lurasidone Hydrochloride Generics Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Lurasidone Hydrochloride Generics Sales Share by Manufacturers (2020-2025)
Table 12. Global Lurasidone Hydrochloride Generics Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Lurasidone Hydrochloride Generics Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Lurasidone Hydrochloride Generics by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lurasidone Hydrochloride Generics as of 2024)
Table 16. Global Lurasidone Hydrochloride Generics Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Lurasidone Hydrochloride Generics Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Lurasidone Hydrochloride Generics Manufacturing Base and Headquarters
Table 19. Global Lurasidone Hydrochloride Generics Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Lurasidone Hydrochloride Generics Sales by Type (2020-2025) & (K Units)
Table 23. Global Lurasidone Hydrochloride Generics Sales by Type (2026-2031) & (K Units)
Table 24. Global Lurasidone Hydrochloride Generics Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Lurasidone Hydrochloride Generics Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Lurasidone Hydrochloride Generics ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Lurasidone Hydrochloride Generics Sales by Application (2020-2025) & (K Units)
Table 29. Global Lurasidone Hydrochloride Generics Sales by Application (2026-2031) & (K Units)
Table 30. Lurasidone Hydrochloride Generics High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Lurasidone Hydrochloride Generics Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Lurasidone Hydrochloride Generics Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Lurasidone Hydrochloride Generics ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Lurasidone Hydrochloride Generics Growth Accelerators and Market Barriers
Table 37. North America Lurasidone Hydrochloride Generics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Lurasidone Hydrochloride Generics Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Lurasidone Hydrochloride Generics Growth Accelerators and Market Barriers
Table 40. Europe Lurasidone Hydrochloride Generics Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Lurasidone Hydrochloride Generics Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Lurasidone Hydrochloride Generics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Lurasidone Hydrochloride Generics Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Lurasidone Hydrochloride Generics Growth Accelerators and Market Barriers
Table 45. Southeast Asia Lurasidone Hydrochloride Generics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Lurasidone Hydrochloride Generics Investment Opportunities and Key Challenges
Table 47. Central and South America Lurasidone Hydrochloride Generics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Lurasidone Hydrochloride Generics Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Lurasidone Hydrochloride Generics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Accord Healthcare Corporation Information
Table 51. Accord Healthcare Description and Major Businesses
Table 52. Accord Healthcare Product Models, Descriptions and Specifications
Table 53. Accord Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Accord Healthcare Sales Value Proportion by Product in 2024
Table 55. Accord Healthcare Sales Value Proportion by Application in 2024
Table 56. Accord Healthcare Sales Value Proportion by Geographic Area in 2024
Table 57. Accord Healthcare Lurasidone Hydrochloride Generics SWOT Analysis
Table 58. Accord Healthcare Recent Developments
Table 59. Amneal Corporation Information
Table 60. Amneal Description and Major Businesses
Table 61. Amneal Product Models, Descriptions and Specifications
Table 62. Amneal Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Amneal Sales Value Proportion by Product in 2024
Table 64. Amneal Sales Value Proportion by Application in 2024
Table 65. Amneal Sales Value Proportion by Geographic Area in 2024
Table 66. Amneal Lurasidone Hydrochloride Generics SWOT Analysis
Table 67. Amneal Recent Developments
Table 68. Dr. Reddy's Laboratories Corporation Information
Table 69. Dr. Reddy's Laboratories Description and Major Businesses
Table 70. Dr. Reddy's Laboratories Product Models, Descriptions and Specifications
Table 71. Dr. Reddy's Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Dr. Reddy's Laboratories Sales Value Proportion by Product in 2024
Table 73. Dr. Reddy's Laboratories Sales Value Proportion by Application in 2024
Table 74. Dr. Reddy's Laboratories Sales Value Proportion by Geographic Area in 2024
Table 75. Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics SWOT Analysis
Table 76. Dr. Reddy's Laboratories Recent Developments
Table 77. MSN Corporation Information
Table 78. MSN Description and Major Businesses
Table 79. MSN Product Models, Descriptions and Specifications
Table 80. MSN Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. MSN Sales Value Proportion by Product in 2024
Table 82. MSN Sales Value Proportion by Application in 2024
Table 83. MSN Sales Value Proportion by Geographic Area in 2024
Table 84. MSN Lurasidone Hydrochloride Generics SWOT Analysis
Table 85. MSN Recent Developments
Table 86. Sun Pharmaceuticals Corporation Information
Table 87. Sun Pharmaceuticals Description and Major Businesses
Table 88. Sun Pharmaceuticals Product Models, Descriptions and Specifications
Table 89. Sun Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Sun Pharmaceuticals Sales Value Proportion by Product in 2024
Table 91. Sun Pharmaceuticals Sales Value Proportion by Application in 2024
Table 92. Sun Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
Table 93. Sun Pharmaceuticals Lurasidone Hydrochloride Generics SWOT Analysis
Table 94. Sun Pharmaceuticals Recent Developments
Table 95. Alkem Corporation Information
Table 96. Alkem Description and Major Businesses
Table 97. Alkem Product Models, Descriptions and Specifications
Table 98. Alkem Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Alkem Recent Developments
Table 100. Zydus Corporation Information
Table 101. Zydus Description and Major Businesses
Table 102. Zydus Product Models, Descriptions and Specifications
Table 103. Zydus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Zydus Recent Developments
Table 105. Lupin Corporation Information
Table 106. Lupin Description and Major Businesses
Table 107. Lupin Product Models, Descriptions and Specifications
Table 108. Lupin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Lupin Recent Developments
Table 110. Alembic pharmaceuticals Corporation Information
Table 111. Alembic pharmaceuticals Description and Major Businesses
Table 112. Alembic pharmaceuticals Product Models, Descriptions and Specifications
Table 113. Alembic pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Alembic pharmaceuticals Recent Developments
Table 115. Yangtze River Pharmaceutical Corporation Information
Table 116. Yangtze River Pharmaceutical Description and Major Businesses
Table 117. Yangtze River Pharmaceutical Product Models, Descriptions and Specifications
Table 118. Yangtze River Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Yangtze River Pharmaceutical Recent Developments
Table 120. Qilu Pharmaceutical Corporation Information
Table 121. Qilu Pharmaceutical Description and Major Businesses
Table 122. Qilu Pharmaceutical Product Models, Descriptions and Specifications
Table 123. Qilu Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Qilu Pharmaceutical Recent Developments
Table 125. SJZ No.4 Pharmaceutical Corporation Information
Table 126. SJZ No.4 Pharmaceutical Description and Major Businesses
Table 127. SJZ No.4 Pharmaceutical Product Models, Descriptions and Specifications
Table 128. SJZ No.4 Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. SJZ No.4 Pharmaceutical Recent Developments
Table 130. Zhejiang Huahai Pharmaceutical Corporation Information
Table 131. Zhejiang Huahai Pharmaceutical Description and Major Businesses
Table 132. Zhejiang Huahai Pharmaceutical Product Models, Descriptions and Specifications
Table 133. Zhejiang Huahai Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Zhejiang Huahai Pharmaceutical Recent Developments
Table 135. Hansoh Pharma Corporation Information
Table 136. Hansoh Pharma Description and Major Businesses
Table 137. Hansoh Pharma Product Models, Descriptions and Specifications
Table 138. Hansoh Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Hansoh Pharma Recent Developments
Table 140. YaoPharma Corporation Information
Table 141. YaoPharma Description and Major Businesses
Table 142. YaoPharma Product Models, Descriptions and Specifications
Table 143. YaoPharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. YaoPharma Recent Developments
Table 145. Changzhou Pharmaceutical Factory Corporation Information
Table 146. Changzhou Pharmaceutical Factory Description and Major Businesses
Table 147. Changzhou Pharmaceutical Factory Product Models, Descriptions and Specifications
Table 148. Changzhou Pharmaceutical Factory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Changzhou Pharmaceutical Factory Recent Developments
Table 150. Shandong Jewim Pharmaceutical Corporation Information
Table 151. Shandong Jewim Pharmaceutical Description and Major Businesses
Table 152. Shandong Jewim Pharmaceutical Product Models, Descriptions and Specifications
Table 153. Shandong Jewim Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Shandong Jewim Pharmaceutical Recent Developments
Table 155. Hisun Pharmaceuticals Corporation Information
Table 156. Hisun Pharmaceuticals Description and Major Businesses
Table 157. Hisun Pharmaceuticals Product Models, Descriptions and Specifications
Table 158. Hisun Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Hisun Pharmaceuticals Recent Developments
Table 160. Cisen Pharmaceutical Corporation Information
Table 161. Cisen Pharmaceutical Description and Major Businesses
Table 162. Cisen Pharmaceutical Product Models, Descriptions and Specifications
Table 163. Cisen Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Cisen Pharmaceutical Recent Developments
Table 165. Chia Tai Tianqing Pharmaceutical Corporation Information
Table 166. Chia Tai Tianqing Pharmaceutical Description and Major Businesses
Table 167. Chia Tai Tianqing Pharmaceutical Product Models, Descriptions and Specifications
Table 168. Chia Tai Tianqing Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 169. Chia Tai Tianqing Pharmaceutical Recent Developments
Table 170. Key Raw Materials Distribution
Table 171. Raw Materials Key Suppliers
Table 172. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 173. Milestones in Production Technology Evolution
Table 174. Distributors List
Table 175. Market Trends and Market Evolution
Table 176. Market Drivers and Opportunities
Table 177. Market Challenges, Risks, and Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources


List of Figures
Figure 1. Lurasidone Hydrochloride Generics Product Picture
Figure 2. Global Lurasidone Hydrochloride Generics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 20mg per Tablet Product Picture
Figure 4. 40mg per Tablet Product Picture
Figure 5. 60mg per Tablet Product Picture
Figure 6. 80mg per Tablet Product Picture
Figure 7. 120mg per Tablet Product Picture
Figure 8. Global Lurasidone Hydrochloride Generics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Schizophrenia
Figure 10. Bipolar Depression
Figure 11. Lurasidone Hydrochloride Generics Report Years Considered
Figure 12. Global Lurasidone Hydrochloride Generics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Lurasidone Hydrochloride Generics Revenue (2020-2031) & (US$ Million)
Figure 14. Global Lurasidone Hydrochloride Generics Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Lurasidone Hydrochloride Generics Revenue Market Share by Region (2020-2031)
Figure 16. Global Lurasidone Hydrochloride Generics Sales (2020-2031) & (K Units)
Figure 17. Global Lurasidone Hydrochloride Generics Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Lurasidone Hydrochloride Generics Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Lurasidone Hydrochloride Generics Sales Volume Market Share in 2024
Figure 20. Global Lurasidone Hydrochloride Generics Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. 20mg per Tablet Revenue Market Share by Manufacturer in 2024
Figure 23. 40mg per Tablet Revenue Market Share by Manufacturer in 2024
Figure 24. 60mg per Tablet Revenue Market Share by Manufacturer in 2024
Figure 25. 80mg per Tablet Revenue Market Share by Manufacturer in 2024
Figure 26. 120mg per Tablet Revenue Market Share by Manufacturer in 2024
Figure 27. Global Lurasidone Hydrochloride Generics Sales Market Share by Type (2020-2031)
Figure 28. Global Lurasidone Hydrochloride Generics Revenue Market Share by Type (2020-2031)
Figure 29. Global Lurasidone Hydrochloride Generics Sales Market Share by Application (2020-2031)
Figure 30. Global Lurasidone Hydrochloride Generics Revenue Market Share by Application (2020-2031)
Figure 31. North America Lurasidone Hydrochloride Generics Sales YoY (2020-2031) & (K Units)
Figure 32. North America Lurasidone Hydrochloride Generics Revenue YoY (2020-2031) & (US$ Million)
Figure 33. North America Top 5 Manufacturers Lurasidone Hydrochloride Generics Sales Revenue (US$ Million) in 2024
Figure 34. North America Lurasidone Hydrochloride Generics Sales Volume (K Units) by Type (2020- 2031)
Figure 35. North America Lurasidone Hydrochloride Generics Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 36. North America Lurasidone Hydrochloride Generics Sales Volume (K Units) by Application (2020-2031)
Figure 37. North America Lurasidone Hydrochloride Generics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 38. US Lurasidone Hydrochloride Generics Revenue (2020-2031) & (US$ Million)
Figure 39. Canada Lurasidone Hydrochloride Generics Revenue (2020-2031) & (US$ Million)
Figure 40. Mexico Lurasidone Hydrochloride Generics Revenue (2020-2031) & (US$ Million)
Figure 41. Europe Lurasidone Hydrochloride Generics Sales YoY (2020-2031) & (K Units)
Figure 42. Europe Lurasidone Hydrochloride Generics Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Europe Top 5 Manufacturers Lurasidone Hydrochloride Generics Sales Revenue (US$ Million) in 2024
Figure 44. Europe Lurasidone Hydrochloride Generics Sales Volume (K Units) by Type (2020-2031)
Figure 45. Europe Lurasidone Hydrochloride Generics Sales Revenue (US$ Million) by Type (2020-2031)
Figure 46. Europe Lurasidone Hydrochloride Generics Sales Volume (K Units) by Application (2020-2031)
Figure 47. Europe Lurasidone Hydrochloride Generics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 48. Germany Lurasidone Hydrochloride Generics Revenue (2020-2031) & (US$ Million)
Figure 49. France Lurasidone Hydrochloride Generics Revenue (2020-2031) & (US$ Million)
Figure 50. U.K. Lurasidone Hydrochloride Generics Revenue (2020-2031) & (US$ Million)
Figure 51. Italy Lurasidone Hydrochloride Generics Revenue (2020-2031) & (US$ Million)
Figure 52. Russia Lurasidone Hydrochloride Generics Revenue (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Lurasidone Hydrochloride Generics Sales YoY (2020-2031) & (K Units)
Figure 54. Asia-Pacific Lurasidone Hydrochloride Generics Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Asia-Pacific Top 8 Manufacturers Lurasidone Hydrochloride Generics Sales Revenue (US$ Million) in 2024
Figure 56. Asia-Pacific Lurasidone Hydrochloride Generics Sales Volume (K Units) by Type (2020- 2031)
Figure 57. Asia-Pacific Lurasidone Hydrochloride Generics Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 58. Asia-Pacific Lurasidone Hydrochloride Generics Sales Volume (K Units) by Application (2020-2031)
Figure 59. Asia-Pacific Lurasidone Hydrochloride Generics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 60. Indonesia Lurasidone Hydrochloride Generics Revenue (2020-2031) & (US$ Million)
Figure 61. Japan Lurasidone Hydrochloride Generics Revenue (2020-2031) & (US$ Million)
Figure 62. South Korea Lurasidone Hydrochloride Generics Revenue (2020-2031) & (US$ Million)
Figure 63. China Taiwan Lurasidone Hydrochloride Generics Revenue (2020-2031) & (US$ Million)
Figure 64. India Lurasidone Hydrochloride Generics Revenue (2020-2031) & (US$ Million)
Figure 65. Central and South America Lurasidone Hydrochloride Generics Sales YoY (2020-2031) & (K Units)
Figure 66. Central and South America Lurasidone Hydrochloride Generics Revenue YoY (2020-2031) & (US$ Million)
Figure 67. Central and South America Top 5 Manufacturers Lurasidone Hydrochloride Generics Sales Revenue (US$ Million) in 2024
Figure 68. Central and South America Lurasidone Hydrochloride Generics Sales Volume (K Units) by Type (2021-2031)
Figure 69. Central and South America Lurasidone Hydrochloride Generics Sales Revenue (US$ Million) by Type (2020-2031)
Figure 70. Central and South America Lurasidone Hydrochloride Generics Sales Volume (K Units) by Application (2020-2031)
Figure 71. Central and South America Lurasidone Hydrochloride Generics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 72. Brazil Lurasidone Hydrochloride Generics Revenue (2020-2025) & (US$ Million)
Figure 73. Argentina Lurasidone Hydrochloride Generics Revenue (2020-2025) & (US$ Million)
Figure 74. Middle East, and Africa Lurasidone Hydrochloride Generics Sales YoY (2020-2031) & (K Units)
Figure 75. Middle East and Africa Lurasidone Hydrochloride Generics Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Middle East and Africa Top 5 Manufacturers Lurasidone Hydrochloride Generics Sales Revenue (US$ Million) in 2024
Figure 77. Middle East and Africa Lurasidone Hydrochloride Generics Sales Volume (K Units) by Type (2021-2031)
Figure 78. South America Lurasidone Hydrochloride Generics Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Middle East and Africa Lurasidone Hydrochloride Generics Sales Volume (K Units) by Application (2020-2031)
Figure 80. Middle East and Africa Lurasidone Hydrochloride Generics Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. GCC Countries Lurasidone Hydrochloride Generics Revenue (2020-2025) & (US$ Million)
Figure 82. Turkey Lurasidone Hydrochloride Generics Revenue (2020-2025) & (US$ Million)
Figure 83. Egypt Lurasidone Hydrochloride Generics Revenue (2020-2025) & (US$ Million)
Figure 84. South Africa Lurasidone Hydrochloride Generics Revenue (2020-2025) & (US$ Million)
Figure 85. Lurasidone Hydrochloride Generics Industry Chain Mapping
Figure 86. Regional Lurasidone Hydrochloride Generics Manufacturing Base Distribution (%)
Figure 87. Global Lurasidone Hydrochloride Generics Production Market Share by Region (2020-2031)
Figure 88. Lurasidone Hydrochloride Generics Production Process
Figure 89. Regional Lurasidone Hydrochloride Generics Production Cost Structure
Figure 90. Channels of Distribution (Direct Vs Distribution)
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit